{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:54:31Z","timestamp":1740149671375,"version":"3.37.3"},"reference-count":132,"publisher":"Informa UK Limited","issue":"9","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Funds of China","doi-asserted-by":"crossref","award":["81873078","81374051"],"award-info":[{"award-number":["81873078","81374051"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Pharmacology"],"published-print":{"date-parts":[[2020,9,1]]},"DOI":"10.1080\/17512433.2020.1805315","type":"journal-article","created":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T07:49:49Z","timestamp":1596527389000},"page":"957-975","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Medication therapy strategies for the coronavirus disease 2019 (COVID-19): recent progress and challenges"],"prefix":"10.1080","volume":"13","author":[{"given":"Xiaolei","family":"Yang","sequence":"first","affiliation":[{"name":"School of Pharmacy, Fudan University, Shanghai, P.R. China"},{"name":"Minhang Hospital, Fudan University, Shanghai, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Fudan University, Shanghai, P.R. China"},{"name":"Minhang Hospital, Fudan University, Shanghai, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuping","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Fudan University, Shanghai, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Fudan University, Shanghai, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xubo","family":"Wu","sequence":"additional","affiliation":[{"name":"Minhang Hospital, Fudan University, Shanghai, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Fudan University, Shanghai, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijia","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Fudan University, Shanghai, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weimin","family":"Cai","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Fudan University, Shanghai, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5524-7172","authenticated-orcid":false,"given":"Guo","family":"Ma","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Fudan University, Shanghai, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,8,13]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001017"},{"key":"cit0002","unstructured":"Coronavirus disease (COVID-2019) situation reports. World Health Organization. [cited 2020 Jul 17]. Available from: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/situation-reports."},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6915e3"},{"key":"cit0005","unstructured":"Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7). National health commission & national administration of traditional chinese medicine of the People\u2019s Republic of China. [cited 2020 Mar 3]. Available from: http:\/\/www.nhc.gov.cn\/yzygj\/s7653p\/202003\/46c9294a7dfe4cef80dc7f5912eb1989.shtml."},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15788-7"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2016638"},{"journal-title":"medRxiv","year":"2020","author":"Tang W","key":"cit0008"},{"journal-title":"medRxiv","year":"2020","author":"Chen Z","key":"cit0009"},{"issue":"1","key":"cit0010","volume":"49","author":"Chen JLD","year":"2020","journal-title":"J Zhejiang Univ (Med Sci)"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105949"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2012410"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1844"},{"journal-title":"medRxiv","year":"2020","author":"Magagnoli J","key":"cit0014"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.2174\/092986708784049658"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2013.08.008"},{"issue":"4","key":"cit0017","first-page":"9","volume":"53","author":"Khamitov RA","year":"2008","journal-title":"Vopr Virusol"},{"key":"cit0018","first-page":"E008","volume":"2020","author":"Chen J","journal-title":"Chin J Infect Dis"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.03.060"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.03.002"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-020-1637-5"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0282-0"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.5582\/bst.2020.01047"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa237"},{"key":"cit0026","unstructured":"WHO Director-General\u2019s opening remarks at the media briefing on COVID-19-25 May 2020. World Health Organization. [cited 2020 May 25]. Available from: https:\/\/www.who.int\/dg\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19\u201425-may-2020."},{"key":"cit0027","unstructured":"\u201cSolidarity\u201d clinical trial for COVID-19 treatments. World Health Organization. [cited 2020 Jul 6]. Available from: https:\/\/www.who.int\/zh\/emergencies\/diseases\/novel-coronavirus-2019\/global-research-on-novel-coronavirus-2019-ncov\/solidarity-clinical-trial-for-covid-19-treatments."},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.3109\/14756366.2014.1003215"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1242\/bio.037663"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104779"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv392"},{"issue":"6","key":"cit0032","first-page":"399","volume":"9","author":"Chan KS","year":"2003","journal-title":"Hong Kong Med J"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.2003.012658"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-005-0004-z"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001282"},{"journal-title":"medRxiv","year":"2020","author":"Li Y","key":"cit0036"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31042-4"},{"journal-title":"Lancet","author":"Hung IF-N","key":"cit0038"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2223-y"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104793"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aal3653"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00221-18"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001191"},{"key":"cit0044","unstructured":"GILEAD presents additional data on investigational antiviral remdesivir for treatment of COVID-19. Sciences G. [cited 2020 Jul 10]. Available from: https:\/\/www.gileadchina.com\/en\/news\/press-releases\/2020\/7\/gilead\u2013presents\u2013additional\u2013data\u2013on\u2013investigational\u2013antiviral\u2013remdesivir."},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007764"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2015301"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007016"},{"journal-title":"Lancet","author":"Wang Y","key":"cit0048"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1002\/asia.201900841"},{"journal-title":"Engineering (Beijing, China)","year":"2020","author":"Cai Q","key":"cit0050"},{"journal-title":"medRxiv","year":"2020","author":"Chen C","key":"cit0051"},{"key":"cit0052","unstructured":"Avigan study fails to demonstrate benefit in COVID-19 treatment. Fujita Health University. [cited 2020 Jul 10]. Available from: https:\/\/english.kyodonews.net\/news\/2020\/07\/af1418fc25ba-breaking-news-avigan-clinical-study-shows-no-effectiveness-in-treating-covid-19.html?phrase=Avigan&words=Avigan."},{"key":"cit0053","unstructured":"The interim report of favipiravir (Abigan) observational research. Fujita Health University. [cited 2020 May 26]. Available from: https:\/\/www.fujita-hu.ac.jp\/news\/j93sdv0000005nw1.html."},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25798"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0225806"},{"journal-title":"bioRxiv","year":"2020","author":"Lokugamage KG","key":"cit0056"},{"journal-title":"World J Pediatr","first-page":"219","author":"Shen KL","key":"cit0057"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30127-2"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.05.007"},{"journal-title":"Lancet Rheumatol","author":"Huet T","key":"cit0060"},{"journal-title":"Lancet Rheumatol","author":"Ucciferri C","key":"cit0061"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa538"},{"key":"cit0064","unstructured":"COVID-19 Treatment Guidelines. National Institutes of Health. [cited 2020 Jun 11]. Available from: https:\/\/covid19treatmentguidelines.nih.gov\/."},{"journal-title":"medRxiv","year":"2020","author":"Gritti G","key":"cit0065"},{"key":"cit0066","unstructured":"Regeneron narrow phase III kevzara trial to critical COVID-19 patients. Sanofi. [cited 2020 May 3]. Available from: https:\/\/www.genengnews.com\/news\/sanofi-regeneron-narrow-phase-iii-kevzara-trial-to-critical-covid-19-patients\/."},{"journal-title":"medRxiv","year":"2020","author":"Wan S","key":"cit0067"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30211-7"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0308-3"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.3390\/ijms15034142"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.3390\/cells9040924"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2020.0228"},{"key":"cit0073","unstructured":"Guidelines for clinical research and application of stem cell therapy for new coronavirus pneumonia (COVID-19). Ministry of Science and Technology of the People\u00b4s Republic of China. [cited 2020 Mar 27]. Available from: http:\/\/www.most.gov.cn\/gnwkjdt\/202003\/t20200327_152617.htm."},{"issue":"1","key":"cit0074","first-page":"10","volume":"38","author":"Shanmugaraj B","year":"2020","journal-title":"Asian Pac J Allergy Immunol"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2015.113"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2020.1729069"},{"key":"cit0077","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2381-y"},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.05.025"},{"journal-title":"bioRxiv","year":"2020","author":"Wang K","key":"cit0079"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.3RU0317-090RR"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.3RU1116-477R"},{"journal-title":"medRxiv","year":"2020","author":"Bian H","key":"cit0082"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.1172\/JCI138745"},{"key":"cit0084","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30141-9"},{"key":"cit0085","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4783"},{"key":"cit0086","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1256"},{"key":"cit0087","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2004168117"},{"key":"cit0088","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.03.039"},{"key":"cit0089","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2020.35.e149"},{"key":"cit0090","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.20.20102236"},{"key":"cit0091","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.10044"},{"key":"cit0092","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140200"},{"journal-title":"bioRxiv","year":"2020","author":"Wrapp D","key":"cit0093"},{"journal-title":"bioRxiv","year":"2020","author":"Ahmed SF","key":"cit0094"},{"journal-title":"bioRxiv","year":"2020","author":"Ramaiah A","key":"cit0095"},{"key":"cit0096","unstructured":"COVID-19 Treatment AND Vaccine Tracker. Milken Institude. [cited 2020 Jul 14]. Available from: http:\/\/milken-institute-covid-19-tracker.webflow.io\/#vaccines_intro."},{"journal-title":"Nat Rev Drug Discov","year":"2020","author":"Le T T","key":"cit0097"},{"journal-title":"bioRxiv","year":"2020","author":"Corbett KS","key":"cit0098"},{"key":"cit0099","doi-asserted-by":"crossref","unstructured":"Graham SP, McLean RK, Spencer AJ, et al. Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19. NPJ\u00a0Vaccines. 2020;5:1\u20136","DOI":"10.1038\/s41541-020-00221-3"},{"key":"cit0100","doi-asserted-by":"crossref","unstructured":"Mulligan MJ, Lyke KE, Kitchin N, et al. Phase 1\/2 study to describe the safety and immunogenicity of a COVID-19 RNA vaccine candidate (BNT162b1) in adults 18 to 55 years of age: interim report. medRxiv. 2020\u00a0Jul 1.\u00a0[Epub ahead of print].","DOI":"10.1101\/2020.06.30.20142570"},{"key":"cit0101","unstructured":"INOVIO announces positive interim phase 1 data for INO-4800 vaccine for COVID-19. INOVIO. [cited 2020 Jun 30]. Available from: http:\/\/ir.inovio.com\/news-releases\/news-releases-details\/2020\/INOVIO-Announces-Positive-Interim-Phase-1-Data-For-INO-4800-Vaccine-for-COVID-19\/default.aspx."},{"key":"cit0102","unstructured":"Sinovac Announces Positive Preliminary Results of Phase I\/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19. Sinovac Biotech Ltd. [cited 2020 June 13]. Available from: http:\/\/www.sinovac.com\/?optionid=754&auto_id=904."},{"key":"cit0103","unstructured":"A phase I clinical trial for recombinant novel coronavirus (2019-COV) vaccine (adenoviral vector). Chinese Clinical Trial Register (ChiCTR) - The world health organization international clinical trials registered organization registered platform. [cited 2020 Mar 19]. Available from: http:\/\/www.chictr.org.cn\/showprojen.aspx?proj=51154."},{"key":"cit0104","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2022483"},{"journal-title":"Lancet","year":"2020","author":"Zhu F-C","key":"cit0105"},{"key":"cit0106","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2015.37"},{"key":"cit0107","unstructured":"Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19. Infectious Diseases Society of America. [cited 2020 Apr 4]. Available from: https:\/\/www.idsociety.org\/COVID19guidelines#GRADEfigure."},{"key":"cit0108","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-020-0233-6"},{"key":"cit0109","unstructured":"Clinical management of severe acute respiratory infection when COVID-19 is suspected. World Health Organization. [cited 2020 May 1]. Available from: https:\/\/www.who.int\/publications-detail\/clinical-management-of-severe-acute-respiratoryinfection-when-novel-coronavirus-(ncov)-infection-is-suspected."},{"key":"cit0110","unstructured":"Emergency Use Authorization\u2014COVID-19 Therapeutics. U.S. Food and Drug Administration. [cited 2020 Apr 8]. Available from: https:\/\/www.fda.gov\/emergency-preparedness-and-response\/mcm-legal-regulatory-and-policy-framework\/emergency-use-authorization#covidtherapeutics."},{"key":"cit0111","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002255"},{"key":"cit0112","first-page":"E016","volume":"38","author":"Shanghai Clinical Treatment Expert Group for corona virus disease. Shanghai Clinical Treatment Expert Group for corona virus disease 2019","year":"2020","journal-title":"Chin J Infect Dis"},{"key":"cit0113","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1585"},{"key":"cit0114","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30317-2"},{"key":"cit0115","doi-asserted-by":"publisher","DOI":"10.1378\/chest.129.6.1441"},{"journal-title":"Lancet","year":"2020","author":"Lianhan Shang JZ","key":"cit0116"},{"key":"cit0117","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.0994"},{"key":"cit0118","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.47652"},{"journal-title":"medRxiv","year":"2020","author":"Horby P","key":"cit0119"},{"key":"cit0120","first-page":"E007","volume":"43","author":"Jianping Z","year":"2020","journal-title":"Chin J Tuberc Respir Dis"},{"key":"cit0121","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106455"},{"key":"cit0122","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa102"},{"key":"cit0123","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21072272"},{"key":"cit0124","unstructured":"Clinical treatment plan of plasma from patients with new coronavirus pneumonia during recovery period (trial version 2). National Health Commission of the People\u2019s Republic of China. [cited 2020 Mar 4]. Available from: http:\/\/www.nhc.gov.cn\/yzygj\/s7658\/202003\/61d608a7e8bf49fca418a6074c2bf5a2.shtml."},{"key":"cit0125","unstructured":"Investigational covid-19 convalescent plasma\u2014emergency INDs. U.S. Food and Drug Administration. [cited 2020 May 2]. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/investigational-new-drug-ind-or-device-exemption-ide-process-cber\/investigational-covid-19-convalescent-plasma-emergency-inds."},{"key":"cit0126","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108408"},{"key":"cit0127","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-2836-4"},{"key":"cit0128","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00858-2020"},{"journal-title":"Stem Cells Transl Med","year":"2020","author":"Qu W","key":"cit0129"},{"key":"cit0130","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2015.09.001"},{"key":"cit0131","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000000486"},{"key":"cit0132","unstructured":"Update on new coronavirus pneumonia epidemic. National Health Commission of People\u2019s Repulic China. [cited 2020 Jul 17]. Available from: http:\/\/www.nhc.gov.cn\/xcs\/yqfkdt\/202006\/b192f9a6fc8047f48e28e3af35dde65c.shtml."}],"container-title":["Expert Review of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17512433.2020.1805315","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T15:04:25Z","timestamp":1646319865000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17512433.2020.1805315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,13]]},"references-count":132,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9,1]]}},"alternative-id":["10.1080\/17512433.2020.1805315"],"URL":"https:\/\/doi.org\/10.1080\/17512433.2020.1805315","relation":{},"ISSN":["1751-2433","1751-2441"],"issn-type":[{"type":"print","value":"1751-2433"},{"type":"electronic","value":"1751-2441"}],"subject":[],"published":{"date-parts":[[2020,8,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-06-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}